版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、中樞神經(jīng)系統(tǒng)血管炎第一頁(yè),共三十九頁(yè)。第二頁(yè),共三十九頁(yè)。第三頁(yè),共三十九頁(yè)。第四頁(yè),共三十九頁(yè)。第五頁(yè),共三十九頁(yè)。Classification of CNS vasculitisINFECTIOUS VASCULITIS- Spirochetal (syphilis)- Mycobacterial- Fungal- Rickettsial- Bacterial (purulent) meningitis- Viral- Other organismsNECROTIZING VASCULITIDES- Classic polyarteritis nodosa- Wegeners granul
2、omatosis- Allergic Angitis and granulomatosis (Churg-Strauss)- Necrotizing systemic vasculitis-overlap syndrome- Lymphomatoid granulomatosisVASCULITIS ASSOCIATED WITH COLLAGEN VASCULAR DISEASES- Systemic lupus erythematosus- Rheumatoid arthritis- Scleroderma- Sjogrens syndromeGIANT CELL ARTERITIDES-
3、 Takayasus arteritis- Temporal (cranial) arteritisVASCULITIS ASSOCIATED WITH OTHER SYSTEMIC DISEASES- Behcets disease- Ulcerative colitis- Sarcoidosis- Relapsing polychondritis- Kohlmeier-Degos diseaseHYPERSENSITIVITY VASCULITIDES- Henoch-Schonlein purpura- Drug-induced vasculitides- Chemical vascul
4、itides- Essential mixed cryoglobulinemiaMISCELLANEOUS- Vasculitis associated with neoplasia- Vasculitis associated with radiation- Cogans syndrome- Dermatomyositis-polymyositis- X-linked lymphoproliferative syndrome- Thromboangiitis obliterans- Kawasaki syndromePRIMARY CNS VASCULITIS第六頁(yè),共三十九頁(yè)。Histor
5、y1922 Harbitzs first report.1959 Gravioto and Feigins extensive autopsy descriptions1970s Primary CNS angiitis, Granulomatous angiitis of the CNS, isolated CNS angiitis.1980s High dose steroid and Cyclophosphamide started.Prognosis is very poor without treatment. Mortality is almost 100% without tre
6、atment第七頁(yè),共三十九頁(yè)。Pathology of the isolated CNS vasculitisThe essential feature is a giant cell, granulomatous inflammation of the small arteries and veins, which exhibits a nearly constant affinity for the vessels of the leptomeninges and the branches that arise from them to penetrate the cortex.The
7、size is 2-300 micron.第八頁(yè),共三十九頁(yè)。Animal ModelsIntrvanous injection of Mycoplasma gallisepticum in turkeys produced similar damage as human vasculitis. 第九頁(yè),共三十九頁(yè)。第十頁(yè),共三十九頁(yè)。第十一頁(yè),共三十九頁(yè)。Clinical PresentationAUTOPSYBIOPSYSYMPTOMS OR CASES CASES SIGNS (N = 45) (N = 26)_Altered mentation 3976%1142%Headache 2
8、9641350Hemiparesis 20441142 Stupor or coma 1942 415Dysphasia 14311142Seizures 1329 831“Eye signs”1533 312Paraparesis1124 415Ataxia 818 935Fever 818 312Papilledema 920 1 4Weight Loss 818 0 0 第十二頁(yè),共三十九頁(yè)。Diagnostic Testing-1Labs: CBCAnti-BM abs, ANCA, ACE, SSA, SSB, FANA, RF, Cryoglobulin, etcESR, C-re
9、active proteinNormal ESR for man is age/2, for women is (age +10)/2.Corrected ESR = ESR (standard Hct-actual Hct) x 1.75. Standard Hct is 45 for man, 42 for women.第十三頁(yè),共三十九頁(yè)。Initial ESR (n=47)Less than 20 mm/hr 22 47%21-40 14 30%41-60 7 15%61-80 3 6% 81 1 2%第十四頁(yè),共三十九頁(yè)。Diagnostic studies for CNS vasc
10、ulitisTESTSENSITIVITY ESTIMATED SPECIFICITYCT33-50% Data not available(even lbiopsy-proven cases) no pathognomonic findingsMRI50-100% Data not available(It approaches 100% in histo- no patholognomonic findings logically confirmed cases, and is lowest in those diagnosedonly by angiography)ANGI-30-100
11、% 22%ography(It is less than 40% in Assessed in only one study but histologically confirmed may be higher if vasculitis is cases, and 100% in reports secondary to other causes arenot supported by histology) excluded)BIOPSY75% 80%(The negativity can be due The same pattern of inflammation to the patc
12、hy nature of the can be due to other causesdisease and small tissuesample 第十五頁(yè),共三十九頁(yè)。 Biller“VASCULITIS” Look-Alikes on Cerebral Angiography_CONDITIONAUTHOR(S)_Neoplastic angioendotheliosis Witt et al.Spasm after subarachnoid hemnorrhageFerris and LevineAtherosclerosisFerris and LevineOral contracep
13、tive use Irey et al.Hypertension with pheochromocytomaALrmstrong and Hayes, Postpartum Garner et al. Eclampsia Trommer, Homer, andMigraineSchon and HarrisonPostcoital headache (?)Kapoor, Kendall, TraumaSuwanwela and Surgical manipulation of intracranial arteriesKhodadad“Reversible cerebral segmental
14、 vasoconstriction”Call et al.Sumatriptan and isometheptane第十六頁(yè),共三十九頁(yè)。Diagnostic Testing-3CSF: Very sensitive, but not specific90% abnormal第十七頁(yè),共三十九頁(yè)。Differential Diagnosis1. CVA2. MS3. Infection4. Tumor5. Specific / systemic vasculitis6. Toxic7. Leukodystrophy8. MERRF, MELAS9. Hypertensive encephalo
15、pathy第十八頁(yè),共三十九頁(yè)。第十九頁(yè),共三十九頁(yè)。7-26-087-26-087-26-087-26-088-3-0882 y/o WF with no PMH admitted because of MS change7-26-087-26-08第二十頁(yè),共三十九頁(yè)。第二十一頁(yè),共三十九頁(yè)。第二十二頁(yè),共三十九頁(yè)。第二十三頁(yè),共三十九頁(yè)。第二十四頁(yè),共三十九頁(yè)。第二十五頁(yè),共三十九頁(yè)。第二十六頁(yè),共三十九頁(yè)。第二十七頁(yè),共三十九頁(yè)。第二十八頁(yè),共三十九頁(yè)。第二十九頁(yè),共三十九頁(yè)。第三十頁(yè),共三十九頁(yè)。第三十一頁(yè),共三十九頁(yè)。第三十二頁(yè),共三十九頁(yè)。第三十三頁(yè),共三十九頁(yè)。第三十四頁(yè),共三
16、十九頁(yè)。第三十五頁(yè),共三十九頁(yè)。MELAS DNA testingMELAS 3243-tRNA leu 3243GMELAS 3271-tRNA leu T3271CMELAS 3252-tRNA leu A3252GMELAS 3256-tRNA leu C3256TMELAS 3291-tRNA leu T3291CMELAS 13,513-ND5 G13513A第三十六頁(yè),共三十九頁(yè)。第三十七頁(yè),共三十九頁(yè)。Treatment for CNS vasculitis CYTOXIC AGENT CORTICOSTEROIDS_Induction Cyclophosphamide 2mg/
17、kd daily Prednisolone 1mg/kg daily therpay by mouth (max 150mg); lower (max 80mg); Reduce weekly to 4 6 mo dose by 25mg if 60 years WBC 10mg/day by 6 months must be 4.0 x 10 /1Maintenance Azathioprine 2mg/kg daily Prednisolone 5 - 10mg/day therapy6 24 mo MTXEscalation Acute severe disease with creatinine 500 umol/1 or pulmonary therapy hemorrhage; Consider 7 10 plasma exchange treatment over 14 days suc
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 光學(xué)儀器的常見(jiàn)故障及維修方法考核試卷
- 2024施工分包合同模板
- 2024英文合同范本對(duì)照代理英文合同范本
- 2024中國(guó)建設(shè)銀行(個(gè)人消費(fèi)借款)保證合同
- 自身免疫性疾病的免疫檢驗(yàn)(免疫學(xué)檢驗(yàn)課件)
- 蘇州科技大學(xué)天平學(xué)院《工程制圖基礎(chǔ)》2022-2023學(xué)年第一學(xué)期期末試卷
- 放射性金屬礦選礦過(guò)程中的治理技術(shù)考核試卷
- 光化學(xué)金屬表面處理技術(shù)考核試卷
- SDZ-216-525-生命科學(xué)試劑-MCE
- Sch-13835-生命科學(xué)試劑-MCE
- GB/T 17892-2024優(yōu)質(zhì)小麥
- 2024-2025學(xué)年七年級(jí)上學(xué)期期中考試英語(yǔ)試題
- 調(diào)酒初級(jí)基礎(chǔ)理論知識(shí)單選題100道及答案解析
- 第5課用發(fā)展的觀點(diǎn)看問(wèn)題2023-2024學(xué)年中職高教版2023哲學(xué)與人生
- 危廢治理項(xiàng)目經(jīng)驗(yàn)-危廢治理案例分析
- 職域行銷BBC模式開(kāi)拓流程-企業(yè)客戶營(yíng)銷技巧策略-人壽保險(xiǎn)營(yíng)銷實(shí)戰(zhàn)-培訓(xùn)課件
- 24秋國(guó)家開(kāi)放大學(xué)《計(jì)算機(jī)系統(tǒng)與維護(hù)》實(shí)驗(yàn)1-13參考答案
- 巖溶地區(qū)建筑地基基礎(chǔ)技術(shù)規(guī)范
- MSA-GRR數(shù)據(jù)自動(dòng)生成工具(已經(jīng)解密)
- 光榮升旗手PPT課件
- 嫁人就嫁蘇東坡
評(píng)論
0/150
提交評(píng)論